Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1387 of 6351
-
New combo therapy for breast cancer aims to outsmart drug resistance
Disease control Recruiting nowSingle agent endocrine therapy (ET), with selective estrogen receptor degraders (SERDs; i.e. fulvestrant or elacestrant), is an option for patients with pre-treated hormone receptor-positive (HR+) breast cancer (BC) with indolent behaviour beyond the first line therapy with CDK4/…
Phase 2 • Sponsor: European Institute of Oncology • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New drug targets genetic weakness in mesothelioma tumors
Disease control Not yet recruitingBy incorporating a platform trial protocol design, SELECTmeso will spearhead a next-generation precision medicine trial platform in relapsed mesothelioma for the UK enabling early evaluation of hypothesis-driven targeted therapies. The SELECTmeso Platform trial protocol allows in…
Phase 2 • Sponsor: University of Southampton • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New combo vaccine for kids could replace current shot
Vaccine Recruiting nowThis study is evaluating the immunogenicity and safety of intramuscular administration of the investigational MMRVNS vaccine compared to intramuscular administration of the MMRV (Merck's measles, mumps, rubella and varicella) vaccine (ProQuad) that is already licensed for this ro…
Phase 3 • Sponsor: GlaxoSmithKline • Aim: Vaccine
Last updated Jul 10, 2026 00:00 UTC
-
Can a coach help men with HIV stay healthy? south africa trial aims to find out
Disease control Not yet recruitingDeveloped in South Africa using extensive input from community members and healthcare professionals, Coach Mpilo is a peer support intervention that was designed to improve health outcomes for men living with HIV. Coach Mpilo engages men living with HIV as coaches who provide sup…
Sponsor: University of Cape Town • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Can cervical cancer patients stop immunotherapy early? new study investigates
Disease control Recruiting nowThis is a nationwide, multicenter, registry-based prospective cohort study to assess real-world effectiveness of treatment with a pembrolizumab containing regimen in persistent, recurrent, or metastatic cervical cancer. Patients in the observation cohort continue treatment accord…
Phase 4 • Sponsor: University Medical Center Groningen • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Light therapy wearables could ease Alzheimer's sleep troubles
Symptom relief By invitation onlyBy 2025, Taiwan will become a super-aged society, with the number of Alzheimer's disease patients continuing to rise. However, the vast majority of dementia patients experience "behavioral and psychological symptoms of dementia" (BPSD), such as circadian rhythm disruptions and sl…
Sponsor: China Medical University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
One-Legged training might fix strength imbalance and elevate basketball performance
Disease control CompletedThis study evaluated the effects of an eight-week unilateral complex training program on lower-limb strength, inter-limb strength asymmetry, and athletic performance in male basketball players. Participants were randomly assigned to either an experimental group that performed uni…
Sponsor: University of Gaziantep • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Parkinson's breakthrough? exercise and brain zaps show promise
Symptom relief Recruiting nowA controlled, blinded, and randomized clinical study will be carried out in a large sample of people with Parkinson's disease, where the combined effects of physical exercise and transcranial direct curren stimlation (tDCS) on motor function will be evaluated.
Sponsor: Universidad Rey Juan Carlos • Aim: Symptom relief
Last updated Jun 27, 2026 12:06 UTC
-
Could a common ED drug help kids with heart failure?
Disease control Not yet recruitingDilated cardiomyopathy (DCM) is a clinical diagnosis characterized by left ventricular or biventricular dilation and impaired contraction that is not explained by abnormal loading conditions.(1) Both inherited predisposition and environmental factors play an important part in the…
Sponsor: Assiut University • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Could zapping kidney nerves ease heart failure?
Disease control Not yet recruitingThis is a single-center, prospective, single-arm clinical trial to evaluate the efficacy and safety of renal denervation (RDN) using a multi-channel radiofrequency ablation system in patients with symptomatic heart failure, including both heart failure with reduced ejection fract…
Sponsor: Shanghai Golden Leaf MedTec Co. Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Nasal spray vaccine plus immunotherapy shows promise in early throat cancer trial
Disease control Recruiting nowThis phase I, open-label, single-arm trial uses a "3+3" dose-escalation design to evaluate the safety, tolerability, and preliminary efffcacy of intranasal WSK-IM05 vaccine combined with tislelizumab as neoadjuvant therapy in patients with resectable HPV-positive oropharyngeal sq…
Phase 1 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New study hopes to catch cervical cancer recurrence earlier with HPV testing
Knowledge-focused Not yet recruitingCervical cancer is strongly associated with HPV infection, yet current post-treatment follow-up relies on cytology and imaging, which have limited accuracy, particularly after radiotherapy. Emerging evidence suggests that HPV clearance is linked to better outcomes and that HPV te…
Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
New ALS drug TP04HN106 enters human trials
Disease control Recruiting nowThis trial adopts a multicenter, randomized, double-blind, placebo-controlled parallel design. This experiment is divided into two groups: the experimental drug group and the placebo group. Successful participants will be randomly assigned to the two groups, with an expected enr…
Phase 1/2 • Sponsor: Talengen Institute of Life Sciences, Shenzhen, P.R. China. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
AI reads MRI scans to predict brain tumor type before surgery
Knowledge-focused Recruiting nowA vision-language model using preoperative MRI and clinical variables has been developed to simultaneously predict three key molecular markers in midline gliomas: H3K27M, IDH, and 1p/19q. This prospective multicenter study will validate the model's accuracy in preoperative molecu…
Sponsor: Xiangya Hospital of Central South University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Can a simple tape ease carpal tunnel pain?
Symptom relief CompletedCarpal tunnel syndrome is a common condition caused by compression of the median nerve at the wrist. It can result in pain, numbness, tingling, weakness, and difficulty performing daily activities. Conservative treatments, including therapeutic exercises and kinesio taping, are f…
Sponsor: Istanbul Gelisim University • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
VR home therapy could boost stroke arm recovery
Symptom relief Recruiting nowStroke rank second among the top causes of death, affecting millions of people in the worldwide. It has been reported that hemiplegia is the most common sequelae after stroke, accounting for about 50%-70% of all sequelae of the disease. About 75% of stroke patients are accompanie…
Sponsor: Qilu Hospital of Shandong University • Aim: Symptom relief
Last updated Aug 12, 2026 00:00 UTC
-
Tailoring sickle cell drug doses: a new hope for nigerian patients
Knowledge-focused Not yet recruitingThe wide interindividual variability in clinical response to hydroxyurea therapy in the management of sickle cell disease has limited its use. These variabilities have been linked to differences in pharmacodynamics, pharmacokinetics, and pharmacogenetics. This study, therefore, a…
Sponsor: Ochuko Orherhe • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC
-
Hidden pelvic vein issues may sabotage leg vein surgery, study warns
Knowledge-focused OngoingResearch Summary: Impact of Pelvic Congestion Syndrome on Lower Limb Varicose Vein Treatment This prospective cohort study investigates the prevalence of Pelvic Congestion Syndrome (PCS) among women undergoing lower limb varicose vein ablation and its impact on post-operative qu…
Sponsor: Chengdu University of Traditional Chinese Medicine • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Cancer drug dasatinib takes aim at hidden HIV in small trial
Disease control Recruiting nowThis study will test if the medicine dasatinib can lower the hidden amount of HIV in the body, called the HIV "reservoir." It will also check if dasatinib is safe and easy to take for people living with HIV who have a suppressed viral load while on antiretroviral therapy (ART). A…
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Which treatment for early stomach cancer offers the best Long-Term survival?
Knowledge-focused Recruiting nowThe goal of this retrospective observational cohort study is to describe the real-world clinicopathological characteristics, evolving treatment patterns, and long-term oncological outcomes of early gastric cancer (EGC) patients in China, utilizing a large prospective clinical dat…
Sponsor: Beijing Friendship Hospital • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC